11.07.2015 Views

Prescribed Drugs Provider Manual - Iowa Department of Human ...

Prescribed Drugs Provider Manual - Iowa Department of Human ...

Prescribed Drugs Provider Manual - Iowa Department of Human ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Iowa</strong><strong>Department</strong><strong>of</strong> <strong>Human</strong>Services<strong>Provider</strong> and Chapter<strong>Prescribed</strong> <strong>Drugs</strong>Chapter III. <strong>Provider</strong>-Specific PoliciesPage40DateAugust 1, 2013♦ Initial authorizations will be approved for 12 weeks with a baseline Centerfor Neurologic Studies Lability Scale (CNS-LS) questionnaire.♦ Subsequent prior authorizations will be considered at six month intervalswith documented efficacy as seen in an improvement in the CNS-LSquestionnaire.Use form 470-5084, Request for Prior Authorization: Dextromethorphan andQuinidine (Nuedexta), to request prior authorization. Click here to see asample <strong>of</strong> the form.28. Digestive EnzymesPrior authorization is required for all digestive enzymes.Payment for preferred digestive enzymes will be authorized only for cases inwhich there is a clinical diagnosis <strong>of</strong> malabsorption due to pancreaticinsufficiency.Payment for nonpreferred digestive enzymes will be authorized only forcases in which there is documentation <strong>of</strong> previous trial and therapy failurewith a preferred agent.Use form 470-4104, Request for Prior Authorization: Miscellaneous, torequest prior authorization. Click here to see a sample <strong>of</strong> the form.29. Dipeptidyl Peptidase-4 (DPP-4) InhibitorsPrior authorization is required for dipeptidyl peptidase-4 (DPP-4) inhibitorsand DPP-4 inhibitor combinations. Payment will be considered under thefollowing conditions:♦ The patient has a diagnosis <strong>of</strong> Type 2 diabetes mellitus;♦ The patient is 18 years <strong>of</strong> age or older; and♦ The patient has not achieved HbgA1C goals using a combination <strong>of</strong> two ormore antidiabetic medications (metformin, sulfonylurea, thiazolidinedione,or insulin) at maximum tolerated doses unless otherwise contraindicated.Payment for a nonpreferred agent will be authorized only for cases in whichthere is documentation <strong>of</strong> a previous trial and therapy failure with a preferredagent, unless evidence is provided that use <strong>of</strong> these agents would bemedically contraindicated.Use form 470-4897, Request for Prior Authorization: DPP-4 Inhibitors, torequest prior authorization. Click here to see a sample <strong>of</strong> the form.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!